Jacobs Levy Equity Management’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-175,122
| Closed | -$3.41M | – | 1025 |
|
|
2022
Q4 | $3.41M | Sell |
175,122
-20,397
| -10% | -$398K | 0.02% | 461 |
|
|
2022
Q3 | $4.11M | Buy |
195,519
+175,282
| +866% | +$3.68M | 0.03% | 432 |
|
|
2022
Q2 | $394K | Sell |
20,237
-18,644
| -48% | -$363K | ﹤0.01% | 898 |
|
|
2022
Q1 | $856K | Sell |
38,881
-263,677
| -87% | -$5.81M | 0.01% | 781 |
|
|
2021
Q4 | $4.83M | Buy |
302,558
+138,156
| +84% | +$2.2M | 0.03% | 436 |
|
|
2021
Q3 | $3.28M | Buy |
164,402
+91,669
| +126% | +$1.83M | 0.02% | 520 |
|
|
2021
Q2 | $1.26M | Buy |
72,733
+49,394
| +212% | +$854K | 0.01% | 700 |
|
|
2021
Q1 | $463K | Buy |
+23,339
| New | +$463K | ﹤0.01% | 868 |
|